Ready to Improve Your Biomarker Intelligence?

TALK TO A BIOMARKER STRATEGIST
Posts From the monthly archives: "May 2015"

There have been a number of interesting review articles recently discussing the state of the art for personalized/precision medicine, and it’s clear that most commentators believe we are still very much in the early days. Having just completed a quick review of the companion diagnostic tests that have been approved by FDA, I…(Read More)

The California Initiative to Advance Precision Medicine has just been launched, and it is being headed by UCSF’s high profile recent hire, Atul Butte. According to the published statement, the Initiative’s first mission will be to “inventory the public and private precision medicine assets now available in the state.” The goal is then…(Read More)

When evaluating the potential of clinical genomics, a lot of attention is rightly focused on the challenges of interpretation, and the need for more phenotypes to power statistically-driven interpretation of clinically relevant variants. But another challenge exists even before that step, in the way patient samples are collected and prepared. In a recent study…(Read More)